Generation Bio (NASDAQ:GBIO) Earns Buy Rating from Canaccord Genuity Group
Canaccord Genuity Group reissued their buy rating on shares of Generation Bio (NASDAQ:GBIO – Free Report) in a research report released on Monday morning,Benzinga reports. Canaccord Genuity Group currently has a $9.00 target price on the stock. GBIO has been the subject of a number of other reports. Needham & Company LLC reissued a “buy” […]
